spironolactone and hydrochlorothiazide

Generic: spironolactone and hydrochlorothiazide

Labeler: sun pharmaceutical industries, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name spironolactone and hydrochlorothiazide
Generic Name spironolactone and hydrochlorothiazide
Labeler sun pharmaceutical industries, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

hydrochlorothiazide 25 mg/1, spironolactone 25 mg/1

Manufacturer
Sun Pharmaceutical Industries, Inc.

Identifiers & Regulatory

Product NDC 53489-144
Product ID 53489-144_b1902b0c-42e6-4e08-bb4a-959280f33579
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA089534
Listing Expiration 2026-12-31
Marketing Start 1987-07-02

Pharmacologic Class

Established (EPC)
thiazide diuretic [epc] aldosterone antagonist [epc]
Mechanism of Action
aldosterone antagonists [moa]
Chemical Structure
thiazides [cs]
Physiologic Effect
increased diuresis [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 53489144
Hyphenated Format 53489-144

Supplemental Identifiers

RxCUI
198224
UNII
0J48LPH2TH 27O7W4T232
NUI
N0000175359 N0000175419 M0471776 N0000175557 N0000011310

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name spironolactone and hydrochlorothiazide (source: ndc)
Generic Name spironolactone and hydrochlorothiazide (source: ndc)
Application Number ANDA089534 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 25 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE, PLASTIC (53489-144-01)
  • 500 TABLET in 1 BOTTLE, PLASTIC (53489-144-05)
  • 1000 TABLET in 1 BOTTLE, PLASTIC (53489-144-10)
source: ndc

Packages (3)

Ingredients (2)

hydrochlorothiazide (25 mg/1) spironolactone (25 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "b1902b0c-42e6-4e08-bb4a-959280f33579", "openfda": {"nui": ["N0000175359", "N0000175419", "M0471776", "N0000175557", "N0000011310"], "unii": ["0J48LPH2TH", "27O7W4T232"], "rxcui": ["198224"], "spl_set_id": ["d7fa3c79-9f26-415b-8039-eb2acabcf66b"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]", "Aldosterone Antagonist [EPC]"], "pharm_class_moa": ["Aldosterone Antagonists [MoA]"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE, PLASTIC (53489-144-01)", "package_ndc": "53489-144-01", "marketing_start_date": "19870702"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE, PLASTIC (53489-144-05)", "package_ndc": "53489-144-05", "marketing_start_date": "19870702"}, {"sample": false, "description": "1000 TABLET in 1 BOTTLE, PLASTIC (53489-144-10)", "package_ndc": "53489-144-10", "marketing_start_date": "19870702"}], "brand_name": "Spironolactone and Hydrochlorothiazide", "product_id": "53489-144_b1902b0c-42e6-4e08-bb4a-959280f33579", "dosage_form": "TABLET", "pharm_class": ["Aldosterone Antagonist [EPC]", "Aldosterone Antagonists [MoA]", "Increased Diuresis [PE]", "Thiazide Diuretic [EPC]", "Thiazides [CS]"], "product_ndc": "53489-144", "generic_name": "Spironolactone and Hydrochlorothiazide", "labeler_name": "Sun Pharmaceutical Industries, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Spironolactone and Hydrochlorothiazide", "active_ingredients": [{"name": "HYDROCHLOROTHIAZIDE", "strength": "25 mg/1"}, {"name": "SPIRONOLACTONE", "strength": "25 mg/1"}], "application_number": "ANDA089534", "marketing_category": "ANDA", "marketing_start_date": "19870702", "listing_expiration_date": "20261231"}